MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    A case of levodopa responsive parkinsonism due to methanol toxicity, an impact of COVID-19 crisis

    M. Shah, L. Patil, M. Bhatt (Mumbai, India)

    Objective: To report the clinical course of secondary parkinsonism due to methanol toxicity with good levodopa responsiveness in the background of COVID-19 crisis. Background: The…
  • 2022 International Congress

    Changes in the level of glial neurotrophic factor in Parkinson’s disease depending on the form

    B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) depending on the form Background: Neurotrophic factors…
  • 2022 International Congress

    The Rostock International Parkinson’s Disease (ROPAD) Study: Analysis of Monogenic PD Genes

    A. Westenberger, V. Skrahina, C. Beetz, T. Usnich, E-J. Vollstedt, X. Bogdanovic, N. Schell, M. Olmedillas, F. Curado, J. Paul, S. Skobalj, N. Brüggemann, N. Ameziane, I. Csoti, M. Kasten, C. Klein, P. Bauer, A. Rolfs (Lübeck, Germany)

    Objective: The ROPAD study aims to investigate the frequency and spectrum of Parkinson’s disease (PD) genetic causes across a multitude of PD and other movement…
  • 2022 International Congress

    A PROSPECTIVE COHORT STUDY OF COGNITIVE IMPAIRMENT AND CORTISOL LEVELS IN PARKINSON’S DISEASE

    N. Soares, G. Pereira, A. Dutra, N. Artigas, J. Krimberg, B. Monticelli, A. Schumacher-Schuh, R. de Almeida, C. Rieder (Porto Alegre, Brazil)

    Objective: To assess cognitive impairment and cortisol levels in PD in a 14-month cohort study. Background: Cognitive impairment is one of the most common non-motor…
  • 2022 International Congress

    X-Linked Dystonia Parkinsonism as the cause of Isolated Lingual Dystonia (ILD)

    D. Dakay, G. Saranza, Z. Leonardo, C. Klein, N. Brüggemann, A. Westenberger (Mandaue City, Philippines)

    Objective: This report aims to describe a 43-year-old Filipino male with ILD aggravated by speech and swallowing. This paper highlights the importance of including XDP…
  • 2022 International Congress

    Autonomic Nervous System Dysfunction in idiopathic REM sleep behaviour disorder

    Y. Shao, T. Wijratne (Melbourne, Australia)

    Objective: To characterise autonomic impairment in REM sleep behaviour disorders, and to investigate the pathophysiological link between autonomic impairment and REM sleep behaviour disorder Background:…
  • 2022 International Congress

    Conservative iron chelation for Neuroferritinopathy

    F. Marchand, C. Moreau, G. Kuchcinski, V. Huin, L. Defebvre, D. Devos (LILLE, France)

    Objective: Evaluate the safety and efficacy of a conservative mode of iron chelation with deferiprone 30 mg/kg/day in neuroferritinopathy to limit iron-related neurodegeneration and associated…
  • 2022 International Congress

    Clinical Manifestations of Autonomic Dysfunction in Parkinsonism Assessed by COMPASS-31 Questionnaire

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to describe the manifestations of autonomic disorders, including symptoms and related factors, in Parkinsonism cases ​​​​​​​ Background: Parkinsonism is a progressive neurodegenerative…
  • 2022 International Congress

    Atypical parkinsonism related to a rare variant in the PLA2G6 gene

    L. Rabaneda-Lombarte, K. Beyer, L. Ispierto, D. Vilas-Rolan (Badalona, Spain)

    Objective: To describe a patient with atypical parkinsonism, carrier of a rare PLA2G6 gene variant. Background: PLA2G6-associated neurodegeneration (PLAN) results from mutations in PLA2G6 gene…
  • 2022 International Congress

    Long-term non-motor and motor outcome after subthalamic stimulation in Parkinson’s disease

    A. Castrioto, B. Debu, E. Cousin, P. Pelissier, E. Lhommée, A. Bichon, E. Schmitt, A. Kistner, S. Meoni, E. Seigneuret, S. Chabardes, P. Krack, E. Moro, V. Fraix (La Tronche, France)

    Objective: The primary objective of this study was to document the evolution of independence in activities of daily living in people with Parkinson’s disease treated…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley